0001181431-07-052947 8-K 2 20070816 8.01 9.01 20070816 20070816 MYRIAD GENETICS INC 0000899923 2835 870494517 DE 0630 8-K 34 000-26642 071061718 320 WAKARA WAY SALT LAKE CITY UT 84108 320 WAKARA WAY SALT LAKE CITY UT 84108 8-K 1 rrd169714.htm FORM 8-K EX-99.1 2 rrd169714_21412.htm THE REGISTRANT'S PRESS RELEASE DATED AUGUST 16, 2007 CONCERNING THE INITIATION OF A THIRD PHASE 2 HUMAN CLINICAL TRIAL OF AZIXA IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER THAT HAS SPREAD TO THE BRAIN.